Integrating these datasets with clinical phenotypes observed in CHD patients with pathogenic GATA6 variants, we demonstrate how disrupted molecular programs cause aberrant development of the cardiac outflow tract, pancreas, and diaphragm. Here, GATA6 is linked to coronary artery disorder.